Evidence map›Paper›PMID 42718913›Full record

ReviewJournal of ginseng research2026

Ginsenoside Rb1: From basic mechanisms to therapeutic applications in diabetic complications.

Yinli Zhao, Lusha Wei, Junwen Gong, Shuanghua Zheng, Dan Li, Zhiqiang Ke

Abstract readReview
PubMed Full text at PMC Publisher
In one paragraph

Review in Journal of ginseng research, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Yinli ZhaoSchool of Stomatology and Ophthalmology, Xianning Medical College, Hubei University of Science and Technology, Xianning, Hubei, 437100, China.
Lusha WeiSchool of Basic Medical Sciences, National Demonstration Center for Experimental General Medicine Education, Xianning Medical College, Hubei University of Science and Technology, Xianning, Hubei, 437100, China.
Junwen GongSchool of Basic Medical Sciences, National Demonstration Center for Experimental General Medicine Education, Xianning Medical College, Hubei University of Science and Technology, Xianning, Hubei, 437100, China.
Shuanghua ZhengSchool of Basic Medical Sciences, National Demonstration Center for Experimental General Medicine Education, Xianning Medical College, Hubei University of Science and Technology, Xianning, Hubei, 437100, China.
Dan LiDepartment of Neonatology, The Clinical Research Center for Acute Myocardial Infarction of Hubei Province, Xianning Central Hospital / First Affiliated Hospital of Hubei University of Science and Technology, Xianning, Hubei, 437100, China.
Zhiqiang KeSchool of Stomatology and Ophthalmology, Xianning Medical College, Hubei University of Science and Technology, Xianning, Hubei, 437100, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Diabetes is a globally prevalent chronic metabolic disorder characterized by defective insulin secretion and/or insulin resistance, often leading to various severe complications. As a traditional Chinese medicine,

Indexed as

Diabetes mellitusDiabetic complicationsGinsenoside Rb1Insulin resistanceMulti-target mechanism

Identifiers

PMID42718913
PMCPMC13554435

What Socratic holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.